Cresilon

Since we announced the FDA 510(k) clearance for TRAUMAGEL?, we have been featured in the news around the U.S., highlighting this milestone. This FDA clearance sets the foundation for transforming the standard of care in emergency and military medicine, addressing the 91% of potentially survivable battlefield deaths caused by uncontrolled bleeding.* We want to thank everyone who has supported us on this journey and we are excited to see what is next for TRAUMAGEL?. There is much more to come! Stay tuned for more updates and head to cresilon.com to learn more about TRAUMAGEL?. *Source: Eastridge BJ, Mabry RL, Seguin P, et al. “Death on the battlefield (2001–2011): implications for the future of combat casualty care.” #innovation #lifesciences #biotechnology

Visit us at ICMM booth 46 and learn about TRAUMAGEL? capabilities. #military #lifesciences #innovations

Excited to announce that Cresilon has been selected to exhibit TRAUMAGEL? at the Vizient Innovative Technology Exchange! TRAUMAGEL? is set to transform emergency medicine by controlling moderate to severe bleeding in seconds.? ? Honored to be part of this event and to showcase how TRAUMAGEL? can improve patient outcomes in critical care situations. Click on the link below to learn more. _ Vizient, Inc #Healthcare #Innovation #biotech

As a proud New York-based company, we reflect on the courage shown on 9/11 and remain committed to supporting those who protect and serve.

TRAUMAGEL? is a hemostatic gel designed to control moderate to severe bleeding in seconds. Visit us at AAST booth 417 to learn more! #traumacare #traumasurgeon #biotechnology

Meet us at EMS World to learn how TRAUMAGEL? can control bleeding in seconds. #ems #biotech #hemostasis #lifesciences

TRAUMAGEL at?SOFEX Jordan?2024! Visit us at booth H3-317 to discover how we can control bleeding in seconds. #biotech?#military?#lifesciences

Meet us at booth 503 at Military Health System Research Symposium and learn about the future of hemostasis. #biotech #hemostasis #lifesciences

Cresilon announced today it has received FDA 510(k) clearance for TRAUMAGEL for temporary external use?for controlling?moderate to severe bleeding. This is a major advancement for our company and the fields of emergency medicine and trauma care. Our second FDA clearance brings us much closer to achieving our mission – saving lives by transforming trauma care and setting a new standard in stopping bleeding. “The ability to rapidly stop bleeding at the point of care and halt a life-threatening hemorrhage can be the difference between life and death for people with traumatic?injuries,” said Joe Landolina, CEO and co-founder of Cresilon and inventor of the technology. “The FDA clearance for TRAUMAGEL is a monumental milestone for Cresilon and brings us another step forward in our mission to save lives and transform the standard of care?in emergency medicine. Our proprietary hemostatic gel technology is a game-changer and unlike any other hemostatic agents currently being used.” Stay tuned as we continue moving forward following TRAUMAGEL's FDA clearance. Read more here: https://lnkd.in/gePKpEKy #innovation #technology #lifescience #medtech

Our preclinical study with Walter Reed Army Institute of Research (WRAIR) shows promising results for treating penetrating traumatic brain injury (TBI).?This study evaluated the safety and efficacy of our hemostatic gel technology in treating TBI. Why does this matter? Penetrating TBI (such as from a gunshot or shrapnel) is the most severe form of traumatic head injury and can lead to death, permanent disability, neurodegenerative diseases, and long-term health issues. Since the DOD began tracking and reporting the number of service members diagnosed with TBI, a total of 492,167 service members sustained one or more TBIs, 5,766 of which were classified as penetrating TBI. "TBIs significantly impact the health, preparedness, and resilience of military personnel," said Dr. Anke Scultetus, WRAIR. "The results of this study with Cresilon are encouraging as we work to deliver solutions for medical personnel and our injured service members." Learn more at https://lnkd.in/e6zG4jN8 #TraumaticBrainInjury #HealthcareInnovation #EmergencyMedicine #TRAUMAGEL